Protein oxidation parameters in type 2 diabetic patients with good and poor glycaemic control

Diabetes and Metabolism

Volumn 31, Issue 6, 2005, Pages 551-557

  Cakatay U ^a,b  

^a ISTANBUL UNIVERSITY   (Turkey)

^b NONE   (Turkey)

Author keywords

Carbonyl groups; Glycaemic control; Lipid peroxidation; Protein oxidation; Type 2 diabetes

Indexed keywords

BIOLOGICAL MARKER; CARBONYL DERIVATIVE; GLYCOSYLATED HEMOGLOBIN; HEMOGLOBIN A1C; LIPID HYDROPEROXIDE; THIOL;

ADULT; ARTICLE; BLOOD LEVEL; CLINICAL ARTICLE; CONTROLLED STUDY; DIABETES MELLITUS; FEMALE; GLUCOSE BLOOD LEVEL; GLUCOSE METABOLISM; GLYCEMIC CONTROL; HEMOGLOBIN DETERMINATION; HUMAN; LIPID PEROXIDATION; MALE; NON INSULIN DEPENDENT DIABETES MELLITUS; OXIDATION; STATISTICAL SIGNIFICANCE;

EID: 29344475463     PISSN: 12623636     EISSN: None     Source Type: Journal    
DOI: 10.1016/S1262-3636(07)70230-6     Document Type: Article

References (43)

1. Altomare E, Grattagliano I, Vendemaile G, Micelli FT, Signorile A, Cardia L. Oxidative protein damage in human diabetic eye: evidence of a retinal participation. Eur J Clin Invest 1997;27:141-7
2. Butterfield DA, Koppal T, Howard B, et al. Structural and functional changes in proteins induced by free radical-mediated oxidative stress and protective action of the antioxidants N-tert-butyl-(-phenylnitrone) and vitamin E. Ann NY Acad Sci 1998;854:448-62
3. Stadtman ER, Levine RL. Protein oxidation. Ann N Y Acad Sci 2000;899:191-208
4. Dean RT, Fu S, Stocker R, Davies MJ. Biochemistry and pathology of radical-mediated protein oxidation. Biochem J 1997;324:1-18
5. Stadtman ER, Levine RL. Free radical-mediated oxidation of free amino acids and amino acid residues in proteins. Amino Acids 2003;25:207-18
6. Dalle-Donne I, Giustarini D, Colombo R, Rossi R, Milzani A. Protein carbonylation in human diseases. Trends in Mol Med 2003;9:169-76
7. 1c): functional characteristics and molecular modelling studies. Biophys Chemist 1998;72:323-35
8. Inouye M, Mio T, Sumino K. Glycated hemoglobin and lipid peroxidation in erythrocytes of diabetic patients. Metabolism 1999;48:205-9
9. Kar M, Chakraborti AS. Release of iron from hemoglobin-a possible-source of free radicals in diabetes mellitus. Indian J Exp Biol 1999;37:190-2
10. Sen S, Kar M, Roy A, Chakraborti AS. Effect of nonenzymatic glycation on functional and structural properties of hemoglobin. Biophys Chemist 2005;113:289-98
11. Sundaram RK, Bhaskar A, Vijayalingam S, Viswanathan M, Mohan R, Shanmugasundaram KR. Antioxidant status and lipid peroxidation in type II diabetesmellitus with and without complications. Clin Sci (Lond) 1996;90:255-60
12. Arab K, Steghens JP. Plasma lipid hydroperoxides measurement by an automated xylenol orange method. Anal Biochem 2004;325:158-63
13. Dalle-Donne I, Rossi R, Giustarini D, Milzani A, Colombo R. Protein carbonyl groups as biomarkers of oxidative stress. Clin Chim Acta 2003;329:23-38
14. Bourdon E, Loreau N, Blache D. Glucose and free radicals impair the antioxidant properties of serum albumin. FASEB J 1999;13:233-44
15. Young IS, Woodside JV. Antioxidants in health and disease. J Clin Pathol 2001;54:176-86
16. Hu ML. Measurement of protein thiol groups and glutathione in plasma. Methods Enzymol 1994;233:381-5
17. Matteucci E, Giampietro O. Oxidative stress in families of type 1 diabetic patients. Diabetes Care 2000;23:1182-6
18. Kayali R, Telci A, Çakatay U, et al. Oxidative protein damage parameters in plasma in chronic experimental diabetes in rats. Eur J Med Res 2003;8:307-12
19. Kayali R, Çakatay U, Telci A, Akçay T, Sivas A, Altuǧ T. Decrease in mitochondrial oxidative protein damage parameters in the streptozotocin-diabetic rat. Diabetes Metab Res Rev 2004;20:315-21
20. Alderman C, Shah S, Foreman JC, Chain BM, Katz DR. The role of advanced oxidation protein products in regulation of dendritic cell function. Free Radic Biol Med 2002;32:377-85
21. Witko-Sarsat V, Friedlander M, Capèillere-Blandin C, et al. Advanced oxidation protein products as a novel marker of oxidative stress in uremia. K dney Int 1996;49:1304-13
22. The Expert Committee on the Diagnosis and Classification of Diabetes Mellitus: Report of the Expert Committee on the Diagnosis and Classification of Diabetes Mellitus. Diabetes Care 1997;20:1183-97
23. Bridges AB, Fisher TC, Scot N, McLaren M, Belch JJF. Circadian rhythm of white blood cell aggregation and free radical status in healthy volunteers. Free Radic Res 1992;16:89-97
24. Telci A, Çakatay U, Salman S, Satman İ, Sivas A. Oxidative protein damage in early stage Type 1 diabetic patients. Diabetes Res Clin Pract 2000;50:213-23
25. World Medical Association Declaration Helsinki: ethical principles for medical research involving human subjects. J Postgrad Med 2002;48:206-8
26. Reznick AZ, Packer L. Oxidative damage to proteins: spectrophotometric method for carbonyl assay. Methods Enzymol 1994;233:357-63
27. Nourooz-Zadeh J. Ferrous ion oxidation in presence of xylenol orange for detection of lipid hydroperoxides in plasma. Methods Enzymol 1999;300:58-62
28. Miyata T, Inagi R, Asahi K, et al. Generation of protein carbonyls by glycoxidation and lipoxidation reactions with autooxidation products of ascorbic acid and polyunsaturated fatty acids. FEBS Lett 1998;437:24-8
29. Odetti P, Garibaldi S, Noberasco G, et al. Levels of carbonyl groups in plasma proteins of Type 2 diabetes mellitus subjects. Acta Diabetol 1999;36:179-83
30. Telci A, Çakatay U, Kayali R, et al. Oxidative protein damage in plasma of type 2 diabetic patients. Horm Metab Res 2000;32:40-3
31. Çakatay U, Telci A, Salman S, Satman I, Sivas A. Oxidative protein damage in Type 1 diabetic patients with and without complications. Endocr Res 2000;26:365-79
32. Kesavulu MM, Kameswara Rao B, Giri R, Vijaya J, Subramanyam G, Apparao C. Lipid peroxidation and antioxidant enzyme status in Type 2 diabetics with coronary heart disease. Diabetes Res Clin Pract 2001;53:33-9
33. Nourooz-Zadeh J, Rahimi A, Tajaddini-Sarmandi J, et al. Relationships between plasma measures of oxidative stress, and metabolic control in NIDDM. Diabetologia 1997;40:647-53
34. Takenaka Y, Miki M, Yasuda H, Mino M. The effect of δ-tocopherol as an antioxidant on the oxidation of membrane protein thiols induced by free radicals generated in different sites. Arch Biochem Biophys 1991;285:344-50
35. Shacter E. Protein oxidative damage. Methods Enzymol 2000;319:428-36
36. Hopkins PN, Wu LL, Hunt SC, James BC, Vincent GM, Williams RR. Higher serum bilirubin is associated with decreased risk for early familial coronary artery disease. Arterioscler Thromb Vasc Biol 1996;16:250-5
37. Stocker R, Glazer AN, Ames BN. Antioxidant activity of albumin-bound bilirubin. Proc Natl Acad Sci USA 1987;84:5918-22
38. Neuzil J, Stocker R. Bilirubin attenuates radical-mediated damage to serum albumin. FEBS Lett 1993;331:281-4
39. Wu TW, Carey D, Wu J, Sugiyama H. The cytoprotective effects of bilirubin and biliverdin on rat hepatocytes and human erythrocytes and the impact of albumin. Biochem Cell Biol 1991;69:828-34
40. Wu TW, Wu J, Li RK, Mickle D, Carey D. Albumin-bound bilirubins protect human ventricular myocytes against oxyradical damage. Biochem Cell Biol 1991;69:683-8
41. Wu TW, Fung KP, Yang CC. Unconjugated bilirubin inhibits the oxidation of human low density lipoprotein better than Trolox. Life Sci 1994;54:P447-P81
42. Ko GT, Chan JC, Woo J, et al. Serum bilirubin and cardiovascular risk factors in a Chinese population. J Cardiovasc Risk 1996;3:459-63
43. Memişoǧullar R, Tays S, Bakan E, Çapoǧlu I. Antioxidant status and lipid peroxidation in type II diabetes mellitus. Cell Biochem Funct 2003;21:291-6